Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer

International Journal of Cancer. Journal International Du Cancer
Sae-Won HanNoe Kyeong Kim

Abstract

Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapy-refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of response, we have investigated the tumoral expression of key signaling molecules of EGFR (EGFR, p-EGFR, p-Akt, p-Erk, p-STAT3) by immunohistochemistry and analyzed their correlations with response. Of 65 patients who received gefitinib (250 mg/day) for chemotherapy-refractory NSCLC, there were 14 partial responses (21.5%), 21 stable diseases (32.3%) and 21 progressive diseases (32.3%). Median durations of overall survival and time to progression were 6.7 months and 2.8 months, respectively. Immunohistochemistry was performed in 34 patients with evaluable tissue specimens. EGFR was overexpressed (2+ or 3+) in 32.4% and p-EGFR was positive in 26.5%. The expressions of p-Akt, p-Erk and p-STAT3 were positive (1+ or 2+) in 50%, 38.2% and 79.4%, respectively. The EGFR expression was not correlated with p-EGFR or the downstream molecules. EGFR or p-EGFR status did not correlate with response. Positive expression of p-Erk was significantly associated with poor response (38.1% in -, 14.3% in 1+,...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
May 5, 2001·Pharmacology & Therapeutics·C R Weinstein-OppenheimerJ A McCubrey
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan AlbanellJose Baselga
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Jan 18, 2003·Lancet·Akira InoueToshihiro Nukiwa
Mar 22, 2003·Experimental Cell Research·Robert N JorissenAntony W Burgess
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico CappuzzoLucio Crino
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Mendelsohn, Jose Baselga
Jul 23, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Toru MukoharaJunichi Yoshikawa
Sep 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschWilbur A Franklin
Sep 23, 2003·Journal of Cellular Physiology·Valentina CalòAntonio Russo
Sep 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeshi SuzukiToyoaki Hida
Dec 9, 2003·British Journal of Cancer·H Cortes-Funes, H Soto Parra
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A SantoroH J Soto Parra
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerRobert T Heelan

❮ Previous
Next ❯

Citations

Sep 12, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Weibo CaiXiaoyuan Chen
Apr 12, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Li YangHoujie Liang
Dec 14, 2005·Current Treatment Options in Oncology·Raymond Liu Chai, Jennifer Rubin Grandis
Feb 22, 2011·Advances in Therapy·N MollbergR Salgia
May 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P Dei Tos, I Ellis
Jan 30, 2008·Cell Research·Khandaker Al Zaid Siddiquee, James Turkson
May 2, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shioto SuzukiYoh Dobashi
Jun 24, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marc Ladanyi, William Pao
Oct 13, 2006·Nature Reviews. Cancer·Mukesh K NyatiTheodore S Lawrence
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hsin Hsien YehJuri G Gelovani
May 6, 2008·Carcinogenesis·Alison L Van DykeAnn G Schwartz
Sep 10, 2009·Journal of the National Cancer Institute·Salvatore SienaAlberto Bardelli
Feb 24, 2005·Current Opinion in Oncology·Fred R Hirsch, Samir Witta
Feb 8, 2006·Current Opinion in Oncology·Rafael RosellMiquel Taron
May 28, 2013·The Cancer Journal·Francesca Cottini, Tim Lautenschlaeger
Sep 21, 2006·Journal of Gastroenterology and Hepatology·Milind M JavleMichael G Brattain
May 12, 2007·Pathology International·Satoshi IkedaToshikatsu Shibata
Oct 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Tefurumi Kato, Kazuto Nishio
Aug 9, 2011·Annals of Surgical Oncology·Jules Lin, David G Beer
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Becky A Mercer, Jeanine M D'Armiento
Jan 1, 2009·OncoTargets and Therapy·Emiliano CalvoEnrique Grande
Jul 11, 2006·The Journal of Molecular Diagnostics : JMD·Yasushi YatabeTetsuya Mitsudomi
Jun 15, 2013·Indian Journal of Palliative Care·Asmita Anilkumar MehtaGanesan S Triavadi
Jul 23, 2008·International Journal of Medical Sciences·Xiaozhu Zhang, Alex Chang
Jun 14, 2006·Critical Reviews in Clinical Laboratory Sciences·Finn Edler von Eyben

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.